Search clinical trials for: OPDIVO®
Total 20796 results
-
Celldex TherapeuticsBristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Ovarian Carcinoma-Enrollment Completed | Colorectal Cancer (CRC)-Enrollment Completed | Renal Cell Carcinoma (RCC) (Phase ll Only) | Glioblastoma (GBM) (Phase ll Only)-Enrollment CompletedUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Belgium, Spain, Argentina, Japan, Korea, Republic of
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Central DuPage HospitalZimmer Biomet; Halifax Biomedical Inc.UnknownRadiostereometric Analysis | Vitamin E Liner | Zimmer® Continuum® Acetabular CupUnited States
-
Semmes-Murphey FoundationUnknownPain | Degenerative Disc DiseaseUnited States
-
Bristol-Myers SquibbRecruiting
-
Crozer-Keystone Health SystemSaint Peters University Hospital; Community Medical Center, Toms River, NJCompletedNon Small Cell Lung Cancer | Metastatic Nonsmall Cell Lung CancerUnited States
-
Vyriad, Inc.TerminatedRecurrent Non-Small Cell Lung CancerUnited States
-
AmgenRecruitingMelanomaItaly, Spain, South Africa, Japan, Serbia, Bosnia and Herzegovina, United States, Argentina, Chile, Georgia, Malaysia, Korea, Republic of, France, Germany, Croatia, Thailand, Brazil, Taiwan, Romania, Mexico, Netherlands
-
Matthew GalskyBristol-Myers Squibb; Hoosier Cancer Research NetworkCompletedMetastatic Urothelial CancerUnited States
-
Diwakar DavarAculeus TherapeuticsActive, not recruitingNSCLC | Metastatic Colorectal Carcinoma | Refractory MelanomaUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedSolid Tumor | Hepatocellular Carcinoma Recurrent | Non-Small Cell Lung Cancer RecurrentSpain, United States
-
ExelixisArcus Biosciences, Inc.RecruitingAdvanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid TumorsUnited States
-
University of California, IrvineExelixisRecruitingHCC | Hepatocellular CarcinomaUnited States
-
Jason J. Luke, MDBristol-Myers SquibbTerminated
-
Dana-Farber Cancer InstituteBristol-Myers SquibbCompletedHead and Neck CancerUnited States
-
University Health Network, TorontoMirati Therapeutics Inc.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma MouthCanada
-
Five Prime Therapeutics, Inc.Bristol-Myers SquibbCompletedRenal Cell Carcinoma | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Malignant Glioma | Advanced Solid Tumors | Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; BayerActive, not recruitingEsophagogastric Cancer | HER2-NegativeUnited States
-
Bristol-Myers SquibbActive, not recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingImplant Breast Reconstruction | TiLOOP® Bra Mesh | Bovine Pericardial PatchChina
-
Hospital de BaseNot yet recruitingCoaguChek® XS System | Coagulation Function
-
King Abdulaziz UniversityCompletedEffect of Carriere® Motion™ Appliance on Pharyngeal Airway Dimensions | Effect of Carriere® Motion™ Appliance on Skeletal and Dental MeasurementsSaudi Arabia
-
Johanna Maria VermeulenNanjing University of Chinese Medicine; Mermaid Medicine®Completed
-
Pierre Fabre Dermo CosmetiqueCompleted
-
AllerganCompletedPatients Who Participated in an Intravitreal Brimo PS DDS® StudyFrance, United Kingdom, Korea, Republic of, Czech Republic, Australia, Israel, India, Portugal, Germany, United States, Italy, Philippines
-
HUYABIO International, LLC.Bristol-Myers SquibbRecruitingUnresectable or Metastatic Melanoma | Progressive Brain MetastasisSpain, United States, Italy, Japan, Belgium, France, New Zealand, Brazil, Korea, Republic of, Australia, Germany, Singapore, Czechia, Austria, South Africa, United Kingdom, Puerto Rico
-
AmgenRecruitingMelanomaItaly, Spain, Czechia, Serbia, Estonia, Bosnia and Herzegovina, Portugal, Romania, Georgia, Lithuania, Malaysia, United States, France, Canada, Thailand, Croatia, Mexico, Germany
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsSpain, United States, Netherlands, France, Italy, Belgium
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbRecruitingHead and Neck Squamous Cell Carcinoma (HNSCC)United States
-
Infinity Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedSolid Tumor | Bladder Cancer | Advanced Cancer | Urothelial CarcinomaFrance, Spain, United States, Italy, Czechia, Poland, Serbia
-
Central Clinical Hospital of the Ministry of Internal...CompletedSirolimus-eluting Stainless Steel Coronary Stent Prolim®
-
TriHealth Inc.CompletedContinuous Fitbit® Use
-
B.Braun Médical - CoE ChasseneuilNot yet recruitingThe Performance / Safety of the Celsite® Venous Access Ports
-
Galderma R&DCompleted
-
Duquesne UniversityOsteoStrongActive, not recruiting
-
Piramal Enterprises LimitedProfil Institute for Clinical Research, Inc.Completed
-
Göteborg UniversityRecruitingGingiva AtrophyUnited Arab Emirates
-
University of PittsburghMerck Sharp & Dohme LLC; RTI International; Rite Aid Corp.; Pharmacy Quality AllianceCompletedMedication AdherenceUnited States
-
Immatics US, Inc.RecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerUnited States, Germany
-
Hadassah Medical OrganizationCompletedPulpotomies Primary Teeth | Effectiveness of MedCem MTA® in Pulpotomies Primary TeethIsrael
-
Sarcoma Oncology Research Center, LLCAadi Bioscience, Inc.CompletedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Ewing Sarcoma | Non Small Cell Lung Cancer | Chordoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | PEComa | Desmoid Tumor | Epithelioid Sarcoma | Squamous Cell Carcinoma | MTOR Activating MutationUnited States
-
A.A. Partners, LLCUnknown
-
Hadassah Medical OrganizationCompletedEffectiveness of Biodentine® in Pulpotomies Primary TeethIsrael
-
Southwestern Regional Medical CenterCompletedCarcinoma, Non-Small-Cell LungUnited States
-
University of ChicagoActive, not recruitingLanguage Environments of Children of Low-socioeconomic StatusUnited States
-
Pró Circulação®CompletedResistance TrainingBrazil
-
Croma-Pharma GmbHCompleted
-
RANDCompletedInfant Health Risk FactorsUnited States